Eric R. Shibley, M.D.; Decision and Order, 16783-16784 [2021-06582]
Download as PDF
Federal Register / Vol. 86, No. 60 / Wednesday, March 31, 2021 / Notices
Dated: April 5, 2018.
Charles Wm. Dorman,
U.S. Administrative Law Judge.
[FR Doc. 2021–06583 Filed 3–30–21; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Eric R. Shibley, M.D.; Decision and
Order
jbell on DSKJLSW7X2PROD with NOTICES
On October 16, 2020, the Assistant
Administrator, Diversion Control
Division, Drug Enforcement
Administration (hereinafter, DEA or
Government), issued an Order to Show
Cause (hereinafter, OSC) to Eric R.
Shibley, M.D. (hereinafter, Registrant) of
Seattle, Washington. OSC, at 1. The OSC
proposed the revocation of Registrant’s
Certificate of Registration No.
FN1977290. It alleged that Registrant is
without ‘‘authority to handle controlled
substances in the State of Washington,
the state in which [Registrant is]
registered with the DEA.’’ Id. at 2 (citing
21 U.S.C. 824(a)(3)).
Specifically, the OSC alleged that the
Washington Medical Commission
issued an Ex Parte Order of Summary
Suspension on August 17, 2020. Id. at
1. This Order, according to the OSC,
summarily suspended Registrant’s state
Physician and Surgeon License because
of Registrant’s ‘‘improper prescribing of
controlled substances.’’ Id. at 1–2. The
OSC concluded that because
Registrant’s medical license was
suspended, Registrant lacks the
authority to handle controlled
substances in the State of Washington.
Id. at 2.
The OSC notified Registrant of the
right to request a hearing on the
allegations or to submit a written
statement, while waiving the right to a
hearing, the procedures for electing each
option, and the consequences for failing
to elect either option. Id. at 2 (citing 21
CFR 1301.43). The OSC also notified
Registrant of the opportunity to submit
a corrective action plan. OSC, at 2–3
(citing 21 U.S.C. 824(c)(2)(C)).
Adequacy of Service
A DEA Diversion Investigator
(hereinafter, DI) served the OSC on
Registrant’s legal counsel on October 19,
2020. Request for Final Agency Action,
dated December 31, 2020 (hereinafter,
RFAA), Exhibit (hereinafter, RFAAX) 9
(DI’s Declaration). By email dated
November 2, 2020, Registrant’s counsel
informed the DI that ‘‘he forwarded a
copy of the [OSC] to [Registrant]’’ and
that Registrant ‘‘did not plan to contest
the matters raised in the [OSC].’’ Id. at
VerDate Sep<11>2014
18:54 Mar 30, 2021
Jkt 253001
2; see also RFAAX 5 (Email chain—DEA
and Registrant’s counsel), at 1.
The Government forwarded its RFAA,
along with the evidentiary record, to
this office on December 31, 2020. In its
RFAA, the Government represented that
‘‘more than 30-days have passed since
Registrant received the [OSC]; however,
Registrant has not submitted to DEA a
request for hearing.’’ 1 RFAA, at 2. The
Government requested an issuance of an
agency final order that ‘‘(1) holds that
Registrant has waived his opportunity
for a hearing, and otherwise failed to
respond to the OTSC; and (2) revokes
Registrant’s DEA COR pursuant to 21
U.S.C. 802(21), 823(f) and 824(a)(3).’’ Id.
at 2.
Based on the DI’s Declaration, the
Government’s written representations,
and my review of the record, I find that
the Government accomplished service
of the OSC on Registrant by November
2, 2020. I also find that more than thirty
days have now passed since the
Government accomplished service of
the OSC. Further, based on the
Government’s written representations, I
find that neither Registrant, nor anyone
purporting to represent the Registrant,
requested a hearing, submitted a written
statement while waiving Registrant’s
right to a hearing, or submitted a
corrective action plan. Accordingly, I
find that Registrant has waived the right
to a hearing and the right to submit a
written statement and corrective action
plan. 21 CFR 1301.43(d) and 21 U.S.C.
824(c)(2)(C). I, therefore, issue this
Decision and Order based on the record
submitted by the Government, which
constitutes the entire record before me.
21 CFR 1301.43(e).
Findings of Fact
Registrant’s DEA Registration
Registrant is the holder of DEA
Certificate of Registration No.
FN1977290 at the registered address of
4700 36th Avenue SW, Seattle,
Washington 98126. RFAAX 1, at 1.
Pursuant to this registration, Registrant
is authorized to dispense controlled
substances in schedules II through V as
a practitioner. Id.
The Status of Registrant’s State License
On August 17, 2020, the State of
Washington Department of Health
Washington Medical Commission
(hereinafter, Commission) issued an Ex
Parte Order of Summary Suspension
(hereinafter, Order of Summary
Suspension) suspending Registrant’s
1 The Government also represents that the
Registrant has not ‘‘otherwise filed a response with
the agency following the issuance of the OTSC.’’
RFAA, at 2.
PO 00000
Frm 00083
Fmt 4703
Sfmt 4703
16783
license to practice as a physician and
surgeon in Washington State. RFAAX 3,
at 1. According to the Order of
Summary Suspension, Registrant
prescribed controlled substances on
multiple occasions from January 2,
2020, to July 1, 2020, while under an
Order of Summary Restriction issued by
the Commission. Id. at 2.
The Order of Summary Restriction
issued on January 2, 2020,
‘‘demonstrated Respondent’s
substandard care of patients with regard
to his prescribing of controlled
substances posed an immediate risk to
patients and the public welfare.’’ Id. at
2. The Order of Summary Suspension
concluded that ‘‘[b]ecause [Registrant]
has continued to prescribe controlled
substances in direct violation of the
Commission’s Order, he remains an
imminent threat to public safety.’’ Id.
The Order of Summary Suspension
ordered the summary suspension of
Registrant’s license to practice as a
physician and surgeon ‘‘pending further
disciplinary proceedings by the
Commission.’’ Id. at 3.
According to Washington’s online
records, of which I take official notice,
Registrant’s license is still summarily
suspended.2 Washington State
Department of Health Provider
Credential Search, https://
fortress.wa.gov/doh/
providercredentialsearch/ (last visited
date of signature of this Order).
Washington’s online records show that
Registrant’s medical license remains
revoked. Id.
Accordingly, I find that Registrant
currently is neither licensed to engage
in the practice of medicine nor
registered to dispense controlled
substances in Washington, the state in
which Registrant is registered with the
DEA.
Discussion
Pursuant to 21 U.S.C. 824(a)(3), the
Attorney General is authorized to
suspend or revoke a registration issued
2 Under the Administrative Procedure Act, an
agency ‘‘may take official notice of facts at any stage
in a proceeding—even in the final decision.’’
United States Department of Justice, Attorney
General’s Manual on the Administrative Procedure
Act 80 (1947) (Wm. W. Gaunt & Sons, Inc., Reprint
1979). Pursuant to 5 U.S.C. 556(e), ‘‘[w]hen an
agency decision rests on official notice of a material
fact not appearing in the evidence in the record, a
party is entitled, on timely request, to an
opportunity to show the contrary.’’ Accordingly,
Registrant may dispute my finding by filing a
properly supported motion for reconsideration of
finding of fact within fifteen calendar days of the
date of this Order. Any such motion and response
shall be filed and served by email to the other party
and to Office of the Administrator, Drug
Enforcement Administration at
dea.addo.attorneys@dea.usdoj.gov.
E:\FR\FM\31MRN1.SGM
31MRN1
jbell on DSKJLSW7X2PROD with NOTICES
16784
Federal Register / Vol. 86, No. 60 / Wednesday, March 31, 2021 / Notices
under section 823 of the Controlled
Substances Act (hereinafter, CSA)
‘‘upon a finding that the registrant . . .
has had his State license or registration
suspended . . . [or] revoked . . . by
competent State authority and is no
longer authorized by State law to engage
in the . . . dispensing of controlled
substances.’’ With respect to a
practitioner, the DEA has also long held
that the possession of authority to
dispense controlled substances under
the laws of the state in which a
practitioner engages in professional
practice is a fundamental condition for
obtaining and maintaining a
practitioner’s registration. See, e.g.,
James L. Hooper, M.D., 76 FR 71,371
(2011), pet. for rev. denied, 481 F. App’x
826 (4th Cir. 2012); Frederick Marsh
Blanton, M.D., 43 FR 27,616, 27,617
(1978).
This rule derives from the text of two
provisions of the CSA. First, Congress
defined the term ‘‘practitioner’’ to mean
‘‘a physician . . . or other person
licensed, registered, or otherwise
permitted, by . . . the jurisdiction in
which he practices . . . , to distribute,
dispense, . . . [or] administer . . . a
controlled substance in the course of
professional practice.’’ 21 U.S.C.
802(21). Second, in setting the
requirements for obtaining a
practitioner’s registration, Congress
directed that ‘‘[t]he Attorney General
shall register practitioners . . . if the
applicant is authorized to dispense . . .
controlled substances under the laws of
the State in which he practices.’’ 21
U.S.C. 823(f). Because Congress has
clearly mandated that a practitioner
possess state authority in order to be
deemed a practitioner under the CSA,
the DEA has held repeatedly that
revocation of a practitioner’s registration
is the appropriate sanction whenever he
is no longer authorized to dispense
controlled substances under the laws of
the state in which he practices. See, e.g.,
James L. Hooper, 76 FR at 71,371–72;
Sheran Arden Yeates, M.D., 71 FR
39,130, 39,131 (2006); Dominick A.
Ricci, M.D., 58 FR 51,104, 51,105 (1993);
Bobby Watts, M.D., 53 FR 11,919, 11,920
(1988); Frederick Marsh Blanton, 43 FR
at 27,617.
According to Washington statute, ‘‘A
practitioner may dispense or deliver a
controlled substance to or for an
individual or animal only for medical
treatment or authorized research in the
ordinary course of that practitioner’s
profession.’’ Wash. Rev. Code
§ 69.50.308(j) (West, Westlaw current
with effective legislation through
Chapter 5 of the 2021 Regular Session
of the Washington Legislature).
Additionally, a ‘‘ ‘prescription’ means
VerDate Sep<11>2014
18:54 Mar 30, 2021
Jkt 253001
an order for controlled substances
issued by a practitioner duly authorized
by law or rule in the state of Washington
to prescribe controlled substances
within the scope of his or her
professional practice for a legitimate
medical purpose.’’ Wash. Rev. Code
§ 69.50.101(nn) (West, Westlaw current
with effective legislation through
Chapter 5 of the 2021 Regular Session
of the Washington Legislature). Further,
‘‘practitioner,’’ as defined by
Washington statute, includes, ‘‘[a]
physician under chapter 18.71 RCW.’’
Id. at 69.50.101(mm)(1).
Here, the undisputed evidence in the
record is that Registrant currently lacks
authority to practice medicine in
Washington. As already discussed, a
physician must be a licensed
practitioner to dispense or prescribe a
controlled substance in Washington.
Thus, because Registrant lacks authority
to practice medicine in Washington and,
therefore, is not authorized to handle
controlled substances in Washington,
Registrant is not eligible to maintain a
DEA registration. Accordingly, I will
order that Registrant’s DEA registration
be revoked.
Order
Pursuant to 28 CFR 0.100(b) and the
authority vested in me by 21 U.S.C.
824(a), I hereby revoke DEA Certificate
of Registration No. FN1977290 issued to
Eric R. Shibley. Further, pursuant to 28
CFR 0.100(b) and the authority vested in
me by 21 U.S.C. 823(f), I hereby deny
any pending application of Eric R.
Shibley to renew or modify this
registration, as well as any other
application of Eric R. Shibley, for
additional registration in Washington.
This Order is effective April 30, 2021.
D. Christopher Evans,
Acting Administrator.
[FR Doc. 2021–06582 Filed 3–30–21; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 21–4]
Roozbeh Badii, M.D.; Decision and
Order
On October 15, 2020, the Assistant
Administrator, Diversion Control
Division, Drug Enforcement
Administration (hereinafter, DEA or
Government), issued an Order to Show
Cause (hereinafter, OSC) to Roozbeh
Badii, M.D. (hereinafter, Respondent) of
McLean, Virginia. OSC, at 1. The OSC
proposed the revocation of
PO 00000
Frm 00084
Fmt 4703
Sfmt 4703
Respondent’s Certificate of Registration
No. FB0526307. It alleged that
Respondent is without ‘‘authority to
handle controlled substances in the
State of Virginia, the state in which
[Respondent is] registered with the
DEA.’’ Id. at 2. (citing 21 U.S.C.
824(a)(3)).
Specifically, the OSC alleged that the
Virginia Department of Health
Professions (hereinafter, VDHP) issued
an Order of Mandatory Suspension on
May 12, 2020. OSC, at 2. This Order,
according to the OSC, immediately
suspended Respondent’s Virginia state
medical license. Id. ‘‘The VDHP ruling
was issued following its finding, inter
alia, of a prior ruling by the Maryland
State Board of Physicians suspending
[Respondent’s] medical license in that
state.’’ Id.
The OSC notified Respondent of the
right to request a hearing on the
allegations or to submit a written
statement, while waiving the right to a
hearing, the procedures for electing each
option, and the consequences for failing
to elect either option. Id. (citing 21 CFR
1301.43). The OSC also notified
Respondent of the opportunity to
submit a corrective action plan. OSC, at
3. (citing 21 U.S.C. 824(c)(2)(C)).
By letter dated November 19, 2020,
Respondent timely requested a hearing.1
Hearing Request, at 1. According to the
Hearing Request, Respondent’s Virginia
medical license was suspended because
the board of medicine in the state of
Maryland believed that Dr. Badii
practiced medicine while being
impaired psychologically and the state
of Virginia, ‘‘simply rubber stamped the
findings of the state of Maryland.’’ Id.
Respondent’s Hearing Request also
claimed that ‘‘other states do not
consider him currently impaired in any
capacity,’’ and that Respondent wanted
the opportunity to ‘‘prove that he is
mentally healthy and no current threat
to his patients.’’ Hearing Request, at 1
and 2.
The Office of Administrative Law
Judges put the matter on the docket and
assigned it to Chief Administrative Law
Judge John J. Mulrooney II (hereinafter,
the Chief ALJ). The Chief ALJ issued an
Order and Briefing Schedule dated
November 23, 2020. The Government
timely complied with the Briefing
Schedule by filing a Motion for
Summary Disposition (hereinafter,
MSD) on December 2, 2020. Order
1 The Hearing Request was filed on November 20,
2020. Order and Briefing Schedule, dated
November 23, 2020, at 1. I find that the
Government’s service of the OSC on October 26,
2020, was adequate and that the Hearing Request
was timely filed on November 20, 2020. See also
Recommended Decision, at n.1.
E:\FR\FM\31MRN1.SGM
31MRN1
Agencies
[Federal Register Volume 86, Number 60 (Wednesday, March 31, 2021)]
[Notices]
[Pages 16783-16784]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-06582]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Eric R. Shibley, M.D.; Decision and Order
On October 16, 2020, the Assistant Administrator, Diversion Control
Division, Drug Enforcement Administration (hereinafter, DEA or
Government), issued an Order to Show Cause (hereinafter, OSC) to Eric
R. Shibley, M.D. (hereinafter, Registrant) of Seattle, Washington. OSC,
at 1. The OSC proposed the revocation of Registrant's Certificate of
Registration No. FN1977290. It alleged that Registrant is without
``authority to handle controlled substances in the State of Washington,
the state in which [Registrant is] registered with the DEA.'' Id. at 2
(citing 21 U.S.C. 824(a)(3)).
Specifically, the OSC alleged that the Washington Medical
Commission issued an Ex Parte Order of Summary Suspension on August 17,
2020. Id. at 1. This Order, according to the OSC, summarily suspended
Registrant's state Physician and Surgeon License because of
Registrant's ``improper prescribing of controlled substances.'' Id. at
1-2. The OSC concluded that because Registrant's medical license was
suspended, Registrant lacks the authority to handle controlled
substances in the State of Washington. Id. at 2.
The OSC notified Registrant of the right to request a hearing on
the allegations or to submit a written statement, while waiving the
right to a hearing, the procedures for electing each option, and the
consequences for failing to elect either option. Id. at 2 (citing 21
CFR 1301.43). The OSC also notified Registrant of the opportunity to
submit a corrective action plan. OSC, at 2-3 (citing 21 U.S.C.
824(c)(2)(C)).
Adequacy of Service
A DEA Diversion Investigator (hereinafter, DI) served the OSC on
Registrant's legal counsel on October 19, 2020. Request for Final
Agency Action, dated December 31, 2020 (hereinafter, RFAA), Exhibit
(hereinafter, RFAAX) 9 (DI's Declaration). By email dated November 2,
2020, Registrant's counsel informed the DI that ``he forwarded a copy
of the [OSC] to [Registrant]'' and that Registrant ``did not plan to
contest the matters raised in the [OSC].'' Id. at 2; see also RFAAX 5
(Email chain--DEA and Registrant's counsel), at 1.
The Government forwarded its RFAA, along with the evidentiary
record, to this office on December 31, 2020. In its RFAA, the
Government represented that ``more than 30-days have passed since
Registrant received the [OSC]; however, Registrant has not submitted to
DEA a request for hearing.'' \1\ RFAA, at 2. The Government requested
an issuance of an agency final order that ``(1) holds that Registrant
has waived his opportunity for a hearing, and otherwise failed to
respond to the OTSC; and (2) revokes Registrant's DEA COR pursuant to
21 U.S.C. 802(21), 823(f) and 824(a)(3).'' Id. at 2.
---------------------------------------------------------------------------
\1\ The Government also represents that the Registrant has not
``otherwise filed a response with the agency following the issuance
of the OTSC.'' RFAA, at 2.
---------------------------------------------------------------------------
Based on the DI's Declaration, the Government's written
representations, and my review of the record, I find that the
Government accomplished service of the OSC on Registrant by November 2,
2020. I also find that more than thirty days have now passed since the
Government accomplished service of the OSC. Further, based on the
Government's written representations, I find that neither Registrant,
nor anyone purporting to represent the Registrant, requested a hearing,
submitted a written statement while waiving Registrant's right to a
hearing, or submitted a corrective action plan. Accordingly, I find
that Registrant has waived the right to a hearing and the right to
submit a written statement and corrective action plan. 21 CFR
1301.43(d) and 21 U.S.C. 824(c)(2)(C). I, therefore, issue this
Decision and Order based on the record submitted by the Government,
which constitutes the entire record before me. 21 CFR 1301.43(e).
Findings of Fact
Registrant's DEA Registration
Registrant is the holder of DEA Certificate of Registration No.
FN1977290 at the registered address of 4700 36th Avenue SW, Seattle,
Washington 98126. RFAAX 1, at 1. Pursuant to this registration,
Registrant is authorized to dispense controlled substances in schedules
II through V as a practitioner. Id.
The Status of Registrant's State License
On August 17, 2020, the State of Washington Department of Health
Washington Medical Commission (hereinafter, Commission) issued an Ex
Parte Order of Summary Suspension (hereinafter, Order of Summary
Suspension) suspending Registrant's license to practice as a physician
and surgeon in Washington State. RFAAX 3, at 1. According to the Order
of Summary Suspension, Registrant prescribed controlled substances on
multiple occasions from January 2, 2020, to July 1, 2020, while under
an Order of Summary Restriction issued by the Commission. Id. at 2.
The Order of Summary Restriction issued on January 2, 2020,
``demonstrated Respondent's substandard care of patients with regard to
his prescribing of controlled substances posed an immediate risk to
patients and the public welfare.'' Id. at 2. The Order of Summary
Suspension concluded that ``[b]ecause [Registrant] has continued to
prescribe controlled substances in direct violation of the Commission's
Order, he remains an imminent threat to public safety.'' Id.
The Order of Summary Suspension ordered the summary suspension of
Registrant's license to practice as a physician and surgeon ``pending
further disciplinary proceedings by the Commission.'' Id. at 3.
According to Washington's online records, of which I take official
notice, Registrant's license is still summarily suspended.\2\
Washington State Department of Health Provider Credential Search,
https://fortress.wa.gov/doh/providercredentialsearch/ (last visited
date of signature of this Order). Washington's online records show that
Registrant's medical license remains revoked. Id.
---------------------------------------------------------------------------
\2\ Under the Administrative Procedure Act, an agency ``may take
official notice of facts at any stage in a proceeding--even in the
final decision.'' United States Department of Justice, Attorney
General's Manual on the Administrative Procedure Act 80 (1947) (Wm.
W. Gaunt & Sons, Inc., Reprint 1979). Pursuant to 5 U.S.C. 556(e),
``[w]hen an agency decision rests on official notice of a material
fact not appearing in the evidence in the record, a party is
entitled, on timely request, to an opportunity to show the
contrary.'' Accordingly, Registrant may dispute my finding by filing
a properly supported motion for reconsideration of finding of fact
within fifteen calendar days of the date of this Order. Any such
motion and response shall be filed and served by email to the other
party and to Office of the Administrator, Drug Enforcement
Administration at [email protected].
---------------------------------------------------------------------------
Accordingly, I find that Registrant currently is neither licensed
to engage in the practice of medicine nor registered to dispense
controlled substances in Washington, the state in which Registrant is
registered with the DEA.
Discussion
Pursuant to 21 U.S.C. 824(a)(3), the Attorney General is authorized
to suspend or revoke a registration issued
[[Page 16784]]
under section 823 of the Controlled Substances Act (hereinafter, CSA)
``upon a finding that the registrant . . . has had his State license or
registration suspended . . . [or] revoked . . . by competent State
authority and is no longer authorized by State law to engage in the . .
. dispensing of controlled substances.'' With respect to a
practitioner, the DEA has also long held that the possession of
authority to dispense controlled substances under the laws of the state
in which a practitioner engages in professional practice is a
fundamental condition for obtaining and maintaining a practitioner's
registration. See, e.g., James L. Hooper, M.D., 76 FR 71,371 (2011),
pet. for rev. denied, 481 F. App'x 826 (4th Cir. 2012); Frederick Marsh
Blanton, M.D., 43 FR 27,616, 27,617 (1978).
This rule derives from the text of two provisions of the CSA.
First, Congress defined the term ``practitioner'' to mean ``a physician
. . . or other person licensed, registered, or otherwise permitted, by
. . . the jurisdiction in which he practices . . . , to distribute,
dispense, . . . [or] administer . . . a controlled substance in the
course of professional practice.'' 21 U.S.C. 802(21). Second, in
setting the requirements for obtaining a practitioner's registration,
Congress directed that ``[t]he Attorney General shall register
practitioners . . . if the applicant is authorized to dispense . . .
controlled substances under the laws of the State in which he
practices.'' 21 U.S.C. 823(f). Because Congress has clearly mandated
that a practitioner possess state authority in order to be deemed a
practitioner under the CSA, the DEA has held repeatedly that revocation
of a practitioner's registration is the appropriate sanction whenever
he is no longer authorized to dispense controlled substances under the
laws of the state in which he practices. See, e.g., James L. Hooper, 76
FR at 71,371-72; Sheran Arden Yeates, M.D., 71 FR 39,130, 39,131
(2006); Dominick A. Ricci, M.D., 58 FR 51,104, 51,105 (1993); Bobby
Watts, M.D., 53 FR 11,919, 11,920 (1988); Frederick Marsh Blanton, 43
FR at 27,617.
According to Washington statute, ``A practitioner may dispense or
deliver a controlled substance to or for an individual or animal only
for medical treatment or authorized research in the ordinary course of
that practitioner's profession.'' Wash. Rev. Code Sec. 69.50.308(j)
(West, Westlaw current with effective legislation through Chapter 5 of
the 2021 Regular Session of the Washington Legislature). Additionally,
a `` `prescription' means an order for controlled substances issued by
a practitioner duly authorized by law or rule in the state of
Washington to prescribe controlled substances within the scope of his
or her professional practice for a legitimate medical purpose.'' Wash.
Rev. Code Sec. 69.50.101(nn) (West, Westlaw current with effective
legislation through Chapter 5 of the 2021 Regular Session of the
Washington Legislature). Further, ``practitioner,'' as defined by
Washington statute, includes, ``[a] physician under chapter 18.71
RCW.'' Id. at 69.50.101(mm)(1).
Here, the undisputed evidence in the record is that Registrant
currently lacks authority to practice medicine in Washington. As
already discussed, a physician must be a licensed practitioner to
dispense or prescribe a controlled substance in Washington. Thus,
because Registrant lacks authority to practice medicine in Washington
and, therefore, is not authorized to handle controlled substances in
Washington, Registrant is not eligible to maintain a DEA registration.
Accordingly, I will order that Registrant's DEA registration be
revoked.
Order
Pursuant to 28 CFR 0.100(b) and the authority vested in me by 21
U.S.C. 824(a), I hereby revoke DEA Certificate of Registration No.
FN1977290 issued to Eric R. Shibley. Further, pursuant to 28 CFR
0.100(b) and the authority vested in me by 21 U.S.C. 823(f), I hereby
deny any pending application of Eric R. Shibley to renew or modify this
registration, as well as any other application of Eric R. Shibley, for
additional registration in Washington. This Order is effective April
30, 2021.
D. Christopher Evans,
Acting Administrator.
[FR Doc. 2021-06582 Filed 3-30-21; 8:45 am]
BILLING CODE 4410-09-P